A common treatment for opioid addiction significantly reduces testosterone levels in many male patients; researchers suggest that supplementary testosterone might improve outcomes.
Opioid treatment suppressed testosterone levels in men, yet the therapy left women’s testosterone levels unaltered, according to a study in Scientific Reports.
New research disputes a widely publicized study that linked testosterone replacement therapy with an increased risk of cardiovascular events and all-cause mortality.
New research shows that testosterone therapy does not significantly improve erectile function or lessen mild to moderate aging male symptoms in obese patients with type 2 diabetes mellitus.
Prior studies have reached contradictory conclusions about how strongly low levels of total testosterone correlate with high levels of metabolic syndrome.
Study results indicate androgen-deprivation therapy (ADT) does not extend the lives of men with early-stage prostate cancer.